Category Archives: Pharmaceutical Pricing and Procurement

Max Richtman Interview — Podcast November 20, 2017

The Republican Flim-flam Continues: First They Reduce Taxes for the 1% Enough To Ensure a 1.5 Trillion Dollar Federal Budget Deficit, Then They Cut Billions From Social Security and Medicare To Help Reduce the Deficit They Just Created.  Max Richtman, … Continue reading

Posted in Affordable Care Act, Corporate Welfare, Corruption, Democratic Governance, Domestic Policy, Entitlements, Health Care, Health Care Policy, Health Insurance, Interviews, Medicaid, Medicare, Pharmaceutical Pricing and Procurement, Podcasts, Privatization, Public Health Policy, Social Insurance, Social Security, Special Interest Legislation, Tax Revenues, Taxation, Welfare | Tagged , , , , , , , , , , | Comments Off on Max Richtman Interview — Podcast November 20, 2017

David Brushwood Interview — Podcast May 1, 2017

Martin Shkreli Isn’t the Only Profiteer in the Pharmaceutical Industry: Why Does the U.S., Alone Among Developed Countries, Allow Life-Saving Prescription Drugs To Be Priced Beyond the Reach Of Many Of the Patients Who Need Them? David Brushwood, professor emeritus of Pharmaceutical Outcomes … Continue reading

Posted in Affordable Care Act, Corruption, Health Care, Health Care Delivery, Health Care Policy, Health Insurance, Interviews, Medicaid, Medicare, National Politics, Pharmaceutical Pricing and Procurement, Podcasts, Public Health Policy | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on David Brushwood Interview — Podcast May 1, 2017